Clerio Vision Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$458K
- Investors
-
15
Clerio Vision General Information
Description
Developer of contact lenses designed to overcome the safety and performance issues with existing refractive surgery. The company's lenses consist of laser-induced refractive index correction technology that has the potential to enter the vision correction market, enabling physicians to correct the refractive index in the human cornea and provide better treatment.
Contact Information
Website
www.cleriovision.comCorporate Office
- 1892 South Winton Road
- Rochester, NY 14618
- United States
Corporate Office
- 1892 South Winton Road
- Rochester, NY 14618
- United States
Clerio Vision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | $458K | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series E) | 12-Jan-2021 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 10-Jul-2019 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 27-Jul-2017 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 11-May-2017 | Completed | Generating Revenue | |||
| 3. Grant | 26-Apr-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 05-Feb-2016 | $3.16M | $6.88M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jun-2014 | $3.72M | $3.72M | Completed | Startup |
Clerio Vision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 2,555,584 | $0.001000 | 3% | $1.96 | $1.96 | 1x | $1.96 | 9.21% |
| Series A | 2,635,637 | $0.001000 | 3% | $1.41 | $1.41 | 1x | $1.41 | 9.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Clerio Vision Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Clerio Vision Patents
Clerio Vision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260090916-A1 | Treatment apparatus and method for providing control data for an ophthalmological laser of a treatment apparatus for generating a laser-induced refractive index change | Pending | 30-Sep-2024 | ||
| WO-2025188803-A1 | Chromatic aberration manipulation in the peripheral retina for myopia control | Pending | 08-Mar-2024 | ||
| WO-2025188803-A8 | Chromatic aberration manipulation in the peripheral retina for myopia control | Pending | 08-Mar-2024 | ||
| US-20260086392-A1 | Contact lenses with image quality enhancing annular zone | Pending | 02-Jun-2023 | ||
| WO-2024249786-A1 | Contact lenses with image quality enhancing annular zone | Inactive | 02-Jun-2023 | G02C7/04 |
Clerio Vision Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Clerio Vision Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ATMA Capital | Venture Capital | Minority | ||
| Bridge Point Capital | Family Office | Minority | ||
| Knickerbocker Capital (New York) | Hedge Fund | Minority | ||
| Proxima Capital | Venture Capital | Minority | ||
| Norwest | Venture Capital | Minority |
Clerio Vision Acquisitions (1)
Clerio Vision’s most recent deal was a Merger/Acquisition with Extreme H2O. The deal was made on 15-Jul-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Extreme H2O | 15-Jul-2019 | Merger/Acquisition | Personal Products |
Clerio Vision FAQs
-
When was Clerio Vision founded?
Clerio Vision was founded in 2014.
-
Where is Clerio Vision headquartered?
Clerio Vision is headquartered in Rochester, NY.
-
What is the size of Clerio Vision?
Clerio Vision has 38 total employees.
-
What industry is Clerio Vision in?
Clerio Vision’s primary industry is Therapeutic Devices.
-
Is Clerio Vision a private or public company?
Clerio Vision is a Private company.
-
What is Clerio Vision’s current revenue?
The current revenue for Clerio Vision is .
-
How much funding has Clerio Vision raised over time?
Clerio Vision has raised $48.9M.
-
Who are Clerio Vision’s investors?
ATMA Capital, Bridge Point Capital, Knickerbocker Capital (New York), Proxima Capital, and Norwest are 5 of 15 investors who have invested in Clerio Vision.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
